UNSPSC 51181912: Follitropin or follitropin alfa and follitropin beta

This classification denotes a major gonadotropin secreted by the adenohypophysis (pituitary gland, anterior), sometimes also called follicle-stimulating hormone, and which stimulates GAMETOGENESIS and the supporting cells such as the ovarian GRANULOSA CELLS, the testicular SERTOLI CELLS, and LEYDIG CELLS, and which consists of two noncovalently linked subunits, alpha and beta, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 076WHW89TW.

UNSPSC 51181912 Follitropin or follitropin alfa and follitropin beta is a Commodity code covering synthetic gonadotropin pharmaceuticals used in assisted reproductive therapy and fertility treatment protocols. State and local governments procure these agents primarily through their health and human services agencies, public health departments, Medicaid programs, and state-operated fertility clinics or reproductive health centers that serve uninsured or underinsured populations. The medications support ovulation induction, controlled ovarian hyperstimulation, and male factor infertility treatment within subsidized or publicly funded family planning and reproductive endocrinology services.

The source provides no recent state or local contract opportunities tagged to this code. Without posted RFPs, RFQs, IFBs, or ITBs naming specific issuing bodies, response dates, or geographic activity, no actionable intelligence on buyer concentration, regional spend patterns, or near-term procurement activity is available under this Commodity code.